The estimated Net Worth of Curt R Hartman is at least $12.5 Milione dollars as of 15 June 2023. Mr Hartman owns over 1,000 units of Conmed stock worth over $315,418 and over the last 16 years he sold CNMD stock worth over $10,393,937. In addition, he makes $1,787,620 as Chairman e CEO & Pres at Conmed.
Mr has made over 34 trades of the Conmed stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 1,000 units of CNMD stock worth $136,000 on 15 June 2023.
The largest trade he's ever made was exercising 136,000 units of Conmed stock on 25 November 2020 worth over $5,422,320. On average, Mr trades about 11,728 units every 102 days since 2009. As of 15 June 2023 he still owns at least 4,299 units of Conmed stock.
You can see the complete history of Mr Hartman stock trades at the bottom of the page.
Curt R. Hartman is the Chairman, CEO & Pres at Conmed.
As the Chairman e CEO & Pres of Conmed, the total compensation of Mr Hartman at Conmed is $1,787,620. There are no executives at Conmed getting paid more.
Mr Hartman is 57, he's been the Chairman e CEO & Pres of Conmed since . There are 2 older and 6 younger executives at Conmed. The oldest executive at Conmed Corp. is David R. Murray, 73, who is the Pres of ConMed Electrosurgery.
Curt's mailing address filed with the SEC is C/O CONMED CORP, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.
Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti e Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.
conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500
Conmed executives and other stock owners filed with the SEC include: